BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxycycline
,
rs3825942
,
VEGFA
,
T cell receptor signaling pathway
,
Diabetes mellitus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
prom1 protein human
Summary
General Info
Curated Studies
Most Correlated Studies
Glioblastoma CD133+ and CD133- cells from xenografts cultured in the presence or absence of laminins
Endothelial progenitor (EPCs) and myeloid circulating angiogenic (CACs) cells from SLE or controls
MicroRNA profiling of mobilized-peripheral blood hematopoietic stem cells
Glioblastoma and normal neural cells sorted by CD133
Advanced breast cancer chemotherapy treatment followed by mastectomy
Explore Curated Studies Results
Literature
Most Relevant Literature
Autologous CD133 + Cells and Laser Revascularization in patients with severe Ischemic Cardiomyopathy…
Progression of PROM1-Associated Retinal Degeneration as Determined by Spectral-Domain Optical Cohere…
Genetic and clinical characteristics of PROM1-related retinal degeneration in Korean.
Deep phenotyping of PROM1-associated retinal degeneration.
Dominant Cone Rod Dystrophy, Previously Assigned to a Missense Variant in RIMS1, Is Fully Explained …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Relat…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ